Online Consultation For CAR-T Doctors in Thailand

Chimeric Antigen Receptor T-cell (CAR-T) therapy is an advanced form of immunotherapy that modifies a patient’s own T-cells to fight certain cancers, especially refractory blood cancers. Choosing the right hematologist or oncologist is essential for optimal outcomes.

Choose a Specialist Who Is:

• Board-certified in Hematology, Oncology, or Cellular Therapy
• Experienced with relapsed/refractory leukemia, lymphoma, or myeloma
• Fellowship-trained in Cellular Immunotherapy or Bone Marrow Transplantation
• Associated with institutions offering clinical trials and GMP-certified labs

CAR-T therapy requires state-of-the-art infrastructure, including cellular labs, cryopreservation units, and highly trained care teams, for safe and effective delivery.

Look For:

• MOH-licensed and JCI-accredited hospitals
• GMP-grade labs for T-cell processing and cryopreservation
• Cellular therapy centers with CAR-T access via trial or commercial approval
• In-house bone marrow transplant units and ICU facilities for CRS management

Yes. Thai hospitals offer secure teleconsultation and pre-travel planning.

To Prepare:

• Submit recent pathology, biopsy, and bone marrow reports
• Include imaging (PET-CT, MRI), blood counts, cytogenetics
• Share prior treatment history and chemotherapy protocols
• Provide MRD (Minimal Residual Disease) or relapse status

What Will Be Discussed:

• CAR-T eligibility based on relapse status and biomarker profile
• Process explanation: leukapheresis, T-cell engineering, infusion
• Cost estimate, timeline, inpatient care planning

Phase & Duration

Pre-evaluation & biomarker testing: 5–7 days

T-cell Collection (Apheresis): 1 day

Cell Manufacturing (local or overseas lab): 2–3 weeks

Infusion & monitoring (inpatient): 10–14 days

CRS/CNS toxicity management & rehab; 2–3 weeks

Total Recommended Stay: 4–6 weeks

Yes. Thailand is emerging as a regional hub for cancer immunotherapy.

International Patient Services Include:

• Medical visa support and treatment letters
• Airport and hotel coordination
• Interpretation (English, Chinese, Arabic, Russian, Bahasa)
• Lab coordination with foreign hospitals
• Virtual or cross-border post-discharge monitoring

Credentials to Expect:

• Medical Degree: MD with specialization in Hematology or Medical Oncology
• Fellowship: BMT, Immunotherapy, or Cellular Oncology
• Experience: ≥5 years in managing hematological malignancies or transplant programs
• Memberships: Thai Society of Hematology, ASH, ESMO, or EBMT

You Will Receive:

• A review of clinical and biomarker data
• Eligibility check for CAR-T
• Overview of risks: CRS (Cytokine Release Syndrome), neurotoxicity
• Timeline for T-cell collection, infusion, and recovery
• Post-infusion follow-up protocols and lab tests
• Cost estimate for CAR-T therapy (typically 40–70% less than in the US)

Yes. Platforms like MediGence and major Thai hospitals offer second opinion services.

What’s Included:

• Expert review of scans, histology, MRD, and molecular data
• Alternate options if CAR-T is not feasible (e.g., targeted therapy, BMT)
• Personalised feedback on prognosis, risks, and benefits